Abstract: A method for the automated segmentation of an abnormality in a medical image, including acquiring first image data representative of the medical image; locating a suspicious site at which the abnormality may exist; establishing a seed point within the suspicious site; and preprocessing the suspicious site with a constraint function to produce second image data in which pixel values distant of the seed point are suppressed. Preprocessing includes using an isotropic Gaussian function centered on the seed point as the constraint function, or for example using an isotropic three dimensional Gaussian function centered on the seed point as the constraint function.

Abstract: A method and system for automatically establishing operational parameters of a statistical surveillance system. The method and system performs a frequency domain transition on time dependent data, a first Fourier composite is formed, serial correlation is removed, a series of Gaussian whiteness tests are performed along with an autocorrelation test, Fourier coefficients are stored and a second Fourier composite is formed. Pseudorandom noise is added, a Monte Carlo simulation is performed to establish SPRT missed alarm probabilities and tested with a synthesized signal. A false alarm test is then emperically evaluated and if less than a desired target value, then SPRT probabilities are used for performing surveillance.

Abstract: A process for producing substantially radio-impurity-free Bi-212 is disclosed. An acidic feed solution containing Pb-212 is contacted with an extraction medium to bind the Pb-212 thereto. The extraction medium is rinsed with a second acid solution to remove impurities therefrom, leaving a substantially impurity-free Pb-212-laden extraction medium The Pb-212 grows on the extraction medium to form Bi-212 by radioactive decay. The Bi-212 is then eluted from the extraction medium with an acid solution to form a substantially radio-impurity-free Bi-212 acid solution. An apparatus for carving out this process and a process for the therapeutic use thereof are also disclosed.

Abstract: A recombinant herpes simplex virus genome having modified .gamma..sub.1 34.5 genes incapable of expressing an active ICP34.5 gene product, vaccines comprising the recombinant herpes simplex virus genome methods for immunizing a host against the herpes simplex virus using the recombinant herpes simplex virus genome, and a method for preparing the vaccine are disclosed.

Abstract: A method and system for monitoring a process and determining its condition. Initial data is sensed, a first set of virtual data is produced by applying a system state analyzation to the initial data, a second set of virtual data is produced by applying a neural network analyzation to the initial data and a parity space analyzation is applied to the first and second set of virtual data and also to the initial data to provide a parity space decision about the condition of the process. A logic test can further be applied to produce a further system decision about the state of the process.

Abstract: A new soluble plastid processing enzyme is purified and characterized. cDNAs encoding the enzyme are isolated, allowing recombinant production of the enzyme. The enzyme cleaves precursor polypeptides that are targeted to organelles such as the chloroplasts. The enzyme is useful to produce mature, active proteins in vivo or in vitro. An example of the enzyme is a chloroplast processing enzyme (CPE) with specificity for cleavage that produces functional proteins.

Abstract: Disclosed are immunopotentiating agents, and vaccines thereof, which enhance and/or otherwise modify immune responses, and methods for their preparation and use in vivo. Immunopotentiating agents can be single agents that act directly, adjuvants added concurrently with the agents, or preferably, heteroconjugates wherein the immunopotentiating agent is chemically coupled to the compound against which an immune response is desired. Examples of immunopotentiating agents include monoclonal antibodies and proteins derived from microorganisms (e.g., enterotoxins) which activate T cells. The compounds against which an immune response can be generated, which may be the second component in a heteroconjugate, include compounds from abnormal or diseased tissues such as tumors, or infectious agents, such as viruses, bacteria, fungi, protozoal or metozoal parasites, and can be obtained by natural or recombinant means.

Abstract: Disclosed is a smooth muscle cell specific promoter, the SM22.alpha. gene promoter as well as the murine cDNA and genomic SM22.alpha. nucleic acid sequences. Also disclosed are methods of preventing restenosis following balloon angioplasty and methods of treating asthma based on inhibition of smooth muscle cell proliferation by expressing cell cycle control genes, or contraction inhibiting peptides in smooth muscle cells, under the control of the SM22.alpha. promoter.

Abstract: A method, computer program product, and system for assessing tumor extent in medical temporally acquired images. The method, on which the computer program product and system is based, includes obtaining image data corresponding to temporally acquired images including a tumor and surrounding anatomy and performing variance processing on the obtained image data to derive variance image data defining a variance image indicative of variation of voxels in the temporally acquired medical images. Techniques include novel developments and implementations of breast volume segmentation, breast border removal, lesion enhancement, determination of the bounding sphere, computation of a 3-D search volume, suppression of surrounding structures, and volume growing. Output from the methods yields an estimate of the extent of the tumor (lesion) in the breast.

Abstract: A method and system for analyzing a source of data. The system and method involves initially training a system using a selected data signal, calculating at least two levels of sensitivity using a pattern recognition methodology, activating a first mode of alarm sensitivity to monitor the data source, activating a second mode of alarm sensitivity to monitor the data source and generating a first alarm signal upon the first mode of sensitivity detecting an alarm condition and a second alarm signal upon the second mode of sensitivity detecting an associated alarm condition. The first alarm condition and second alarm condition can be acted upon by an operator and/or analyzed by a specialist or computer program.

Abstract: The present invention provides a process of increasing dopamine production in a cell comprising co-transfecting the cell with one or more expression vectors containing polynucleotides that encode tyrosine hydroxylase, aromatic L-amino acid decarboxylase and GTP cyclohydrolase. Cells transfected with such vectors and the use of such transformed cells to increase dopamine production in the central nervous system of animals are also provided.

Abstract: Novel growth peptides derived from protein factors having molecular weights of about 22 and 45 kDa stimulate mitogenic activity of epithelial, but not fibroblastic cells, in particular, kidney epithelial cells. A source of the factors is scrape-wounded kidney epithelial cells in culture. Synthetic peptides having sixteen amino acids or less, in particular a hexapeptide, YPQGNH (SEQ ID NO: 2) maintain the mitogenic activity. The peptide AQPYPQGNHEASYG (14-Ser) (SEQ ID NO: 15) is effective in reversing acute renal failure in animals. The growth-promoting characteristics of the 22 and 45 kDa proteins and the peptides are useful in treating and diagnosing patients with kidney disease. Nucleotide sequences that encode the factor are useful to develop probes to locate similar factors, to identify genetic disorders involving the factor, and to produce the factor by genetic recombinant methods. The nucleotide sequences and fragments thereof, are also useful for diagnosis and treatment of kidney disorders.

Abstract: The invention relates generally to compositions of and methods for using polynucleotides encoding kappa opioid receptors. In addition to such polynucleotides themselves, the invention relates to expression vectors comprising polynucleotides encoding kappa opioid receptors, recombinant host cells comprising such polynucleotides, and processes for preparing kappa opioid receptor polypeptides.

Abstract: Disclosed is a smooth muscle cell specific promoter, the SM22.alpha. gene promoter as well as the murine cDNA and genomic SM22.alpha. nucleic acid sequences. Also disclosed are methods of preventing restenosis following balloon angioplasty and methods of treating asthma based on inhibition of smooth muscle cell proliferation by expressing cell cycle control genes, or contraction inhibiting peptides in smooth muscle cells, under the control of the SM22.alpha. promoter.

Abstract: An automated method, and a computer storage medium storing instructions for executing the method, for analysis of image features in lung nodule detection in a chest radiographic image represented by digital data, including preprocessing the image to identify candidate nodules in the image; establishing a region of interest (ROI) including a candidate nodule identified in the preprocessing step; performing image enhancement of the candidate nodule within the ROI; obtaining a histogram of accumulated edge gradients as a function of radial angles withing the ROI after performing the image enhancement; and determining whether the candidate nodule is a false positive based on the obtained histogram. A 64.times.64-pixel region of interest (ROI) centered at the candidate location is used. The contrast of the ROI is improved by a two-dimensional background subtraction. A nodule shape matched filter is used for enhancement of the nodular pattern located in the central area of the ROI.

Abstract: The invention provides methods of inducing the production of cytolytic T lymphocytes directed against malignancy or infectious agent by a mammal and treating such disease such that deleterious side effects are minimized and treatment of metastatic melanomas are surprisingly and dramatically improved.

Abstract: A method and apparatus for discrimination of nodules and false positives in digital chest radiographs, using a wavelet snake technique. The wavelet snake is a deformable contour designed to identify the boundary of a relatively round object. The shape of the snake is determined by a set of wavelet coefficients in a certain range of scales. Portions of the boundary of a nodule are first extracted using a multiscale edge representation. The multiscale edges are then fitted by a gradient descent procedure which deforms the shape of a wavelet snake by changing its wavelet coefficients. The degree of overlap between the fitted snake and the multiscale edges is calculated and used as a fit quality indicator for discrimination of nodules and false detections.

Abstract: A computer-aided diagnosis (CAD) method for detection of clustered microcalcifications in digital mammograms based on an image reconstruction using a substantially optimally weighted wavelet transform. Weights at individual scales of the wavelet transform are optimized based on a supervised learning method. In the learning method, an error function represents a difference between a desired output and a reconstructed image obtained from weighted wavelet coefficients of the wavelet transform for a given mammogram. The error function is then minimized by modifying the weights by means of a conjugate gradient algorithm. Performance of the optimally weighted wavelets was evaluated by means of receiver-operating characteristic (ROC) analysis which indicated that the present invention outperformed both a difference-image technique and partial reconstruction method currently used in CAD methods.

Abstract: A foreign gene is inserted into a viral genome under the control of promoter-regulatory regions of the genome, thus providing a vector for the expression of the foreign gene. DNA constructs, plasmid vectors containing the constructs useful for expression of the foreign gene, recombinant viruses produced With the vector, and associated methods are disclosed.

Abstract: A method for sleep quality is disclosed comprising administering an effective amount of N-[1(R)-[(1,2-dihydro-1-methanesulfonylspiro-(3H-indole-3,4'-piperidin)-1' -yl)carbonyl]-2-(phenylmethoxy)-ethyl]-2-amino-2-methylpropanamide methansulfonate.